Portolan Capital Management, LLC Trans Medics Group, Inc. Transaction History

Portolan Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$20.56 - $32.15 $7.81 Million - $12.2 Million	-379,859 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$12.58 - $26.94 $4.78 Million - $10.2 Million	379,859 New	379,859 $10.2 Million
Q4 2021 Feb 14, 2022	SELL	$19.16 - $32.68 $1.5 Million - $2.55 Million	-78,106 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.92 - $34.51 $2.02 Million - $2.7 Million	78,106 New	78,106 $2.59 Million

397

31.7M

466K

286K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $1.96B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Portolan Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Portolan Capital Management, LLC with notifications on news.